Clearside Biomedical, Inc.CLSDNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank33
Year-over-Year Change
EBITDA as a percentage of revenue
Percentile
P33
Within normal range
vs 3Y Ago
-781.1x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | -1463.16% | -422.0% |
| 2023 | -280.31% | +87.4% |
| 2022 | -2220.27% | -118628.0% |
| 2021 | 1.87% | +100.8% |
| 2020 | -224.16% | +83.8% |
| 2019 | -1384.86% | +99.5% |
| 2018 | -275853.33% | -1534.5% |
| 2017 | -16877.10% | -249.2% |
| 2016 | -4833.27% | - |
| 2015 | 0.00% | - |